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1. Introduction 
Native diphtheria toxin molecule (mol. wt. 
62 000) consists of two distinct functional regions, 
fragments A and B of 24 000 and 38 000 daltons 
respectively that are originally connected to each 
other by a disulfide bridge and a peptide bond. The 
latter may be hydrolyzed very easily either 
spontaneously b the proteases of the culture 
medium or by trypsin. This nicked toxin is the 
enzymatically active form of the molecule [1,2]. 
Fragment A catalyzes the transfer of the ADP- 
ribose moiety from NAD to elongation factor 2 (EF2) 
which is inactivated by this modification [3]. 
The decline in EF2 activity is the primary result of 
the action of diphtheria toxin and is responsible for 
the decrease in protein synthesis of the intoxicated 
cells or organisms [4]. 
Although devoid of any enzymatic activity, 
Fragment B is nevertheless needed for the penetration 
of A into the sensitive cells. Its function seems to be 
the recognition of some cell surface receptors and 
to help, in this way, the penetration of A [1,2]. 
No direct measurement of the binding of fragment 
B to cells has been described until now because of 
its insolubility in usual buffers. The only quantitative 
determination f binding was performed by Ittelson 
and Gill [5] with crm 197, a protein isolated by 
Uchida [6] and produced by a mutant oxin gene. 
This protein which apparently has a normal B moiety 
but an inactive fragment A competes with the cell 
surface receptors of toxin. 
The present paper describes the binding of two 
competitive proteins for HeLa cells receptors: 
(a) a nitrated toxin which has lost enzymatic 
activity (and thus toxicity). 
(b) the fragment B itself which has been obtained 
in a very soluble form. 
We also tested for competition diphtheria toxoid, 
the formaldehyde toxified currently used for 
immunization fmen and animals. 
2. Materials and methods 
2.1. Proteins 
Diphtheria toxin: crystallized toxin obtained from 
the Institut Pasteur de Paris in a completely nicked 
form. 
Nitrated toxin: tetranitromethane (100 X molar 
excess) was added to a solution of diphtheria toxin at 
1 mg/ml in 0.05 M Tris-HC1 0.5 M NaC1, pH 8.0. 
The solution was incubated 2 h at 30°C and dialyzed 
to eliminate reagent. Nine tyrosines per toxin mole- 
cule (out of 20) were transformed into 3-nitro- 
tyrosines (determined by amino acid analysis). 
Enzymatic activity was 0.1% of native toxin and 
toxicity less than 0.05% (determined asminimal 
lethal doses in guinea pigs). 
Fragment B: after carboxymethylation of the 
disulfide bridge between A and B, the fragment B
was purified by molecular filtration on Sephadex 
G-200, in 0.05 M Tris-HC1, 6 M Urea pH 8.0 and 
then dialyzed against 0.02 M sodium borate buffer 
0.02 M KC1, pH 8.0, in which it remains oluble. 
Toxoid was prepared as described by Pappenheimer 
[7]. 
2.2. HeLa cell protein synthesis determinations 
Suspensions at4.10 s cells/ml of HeLa cells S-3 
(6 ml) in Eagle's medium with 5% calf serum are 
distributed into 25 ml erlenmeyer flasks and incubated 
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at 37°C in a water bath shaker for 150 min in the 
presence of different amounts of toxin and com- 
petitive protein. []'C] Leucine (0.1/aCi) was then 
added to each flask and the suspension i cubated 
one hour more. 2 ml aliquots were cooled, filtrated 
on millipores, washed with serum-free medium and 
then with 5% trichloroacetic a id. Filters are dried 
and counted by liquid scintillation. 
3. Results 
Fig.1 shows the dose-response curves of the 
action of diphtheria toxin on protein synthesis of 
HeLa cells in the presence of increasing amounts of 
nitrated toxin (fig.lA) fragment B (fig.lB) or 
toxoid (fig. 1 C). 
Nitrated toxin and fragment B show competitive 
properties: the dose-response curves are shifted pro- 
gressively to the right as expected in the presence of 
increasing concentration f a competitive antagonist. 
Toxoid, on the other hand, has no effect on the 
intoxication curve of diphtheria toxin (fig. 1C). This 
formaldehyde detoxified protein has thus a non- 
functional fragment B. 
In order to determine the apparent dissociation 
constant of the two competitive blocking proteins, we 
measured from fig.lA and B, the toxin concentra- 
tion required to give 50% protein synthesis inhibition 
in the presence (T') and in the absence (T) of the 
competitive protein. 
The dissociation constant K d was then calculated 
from the relation T'/T - 1) = I lK  d where I is the 
competitive protein concentration [5]. Fig.2 
represents he logarithmic plot of this relation 
(slope = 1). K d is obtained by determination f the 
competitive protein concentration I for (T~/T - 1) = 1. 
K d values were found to be 1.3.10 -s M for nitrated 
toxin and 0.8.10 -s M for fragment B (fig.2A and B). 
too "~ 1 o o r ~  . 
A . B 
!oo 
°° 8 Z 
- Z 
TOXIN  CONCENTRATION TOXIN CONCENTRATION 
i 100 
o 
~e 
z 
0 
z 
U 
C 
10. O - 1(~. e 1() "7 M 
TOXIN CONCENTRATION 
Fig. 1. HeLa cells protein synthesis inhibition by diphtheria 
toxin. Experiments performed as described under Materials 
and methods. Results are expressed as % of control (without 
toxin). (A) In the presence of nitrated toxin. (o) 5 t~g/ml, 
(.) 10 ug/ml, (+) 20/~g/ml, (-) 40 ~g/ml, (o) without 
nitrated toxin. (B) In the presence of fragment B (o) 0.25 
tag/ml, (,) 2.5 t,g/ml, (+) 7.5 t~g/ml, (*) 25 ug/ml, (e) without 
fragment B. (C) In the presence of toxoid. (o) 5 tzg/ml, 
(=) 10 tag/ml, (+) 25 ug/ml, (e) without oxoid. 
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Fig.2. Logarithmic plot of the relation (T'/T - 1) = I/K' d, 
where I is the competitive antagonist concentration: itrated 
toxin (A) or fragment B (B). Dose ratios T'/T (see text) were 
calculated from fig.lA and B at 50% inhibition. 
Affinity for receptors eems to be at least as good 
as for entire toxin analogs like crm 197 or nitrated 
toxin. 
The value of about 10 -8 M for the dissociation 
constant of the toxin itself proposed by Ittelson and 
Gill [5] seems thus entirely justified. 
For tox0id however, detoxification by formal- 
dehyde seems to have altered not only the enzymatic 
activity of fragment A but also the binding properties 
of fragment B to cells. This alteration may be due 
either to the chemical modification of some essential 
residue (e.g. lysine) or to the presence of methylene 
bridges [9] which would modify the conformational 
properties of the molecule. 
4. Discussion 
Nitrated toxin has biological properties imilar to 
that of the mutant protein crm 197 isolated by 
Uchida [6] : almost completely enzymatically inactive 
(0.1%) and non-toxic (< 0.05%) but with a fragment B 
still able to bind to cell receptors. Moreover, K a 
values are very similar: Ittelson and Gill [5] reported 
a value of about 10 -s M for crm 197 in perfect 
agreement with the value of 1.3.10 -8 M for nitrated 
toxin found in the present study. 
Even after 6 M urea treatment, fragment B in 
borate buffer seems to have recovered the conformational 
structure it possesses in the native toxin: antigenic 
properties remain unaltered [8] and its ability to 
recognize HeLa cells receptors and to compete with 
toxin is demonstrated here. 
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